This article sheds light on Type 2 diabetes, and the importance of holistic management and culturally competent care.​ ...

Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...

Endogenex said the study "demonstrates substantial and durable reduction in insulin resistance and improvement in beta cell ...

Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics ...

Beware! Do not add these 7 dangerously high sugar content summer superfoods to your diet when you have diabetes - they can ...

A study involving Schulich prof Dr. Tamara Spaic combined glucose monitoring and an automated insulin pump for Type 2 ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Researchers at Thomas Jefferson University have found a new way to help. Their study showed that using two diabetes ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

Italy: A recent multicentre real-world study supports the long-term effectiveness of once-weekly semaglutide as a valuable ...

The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular ...